Clinical Trial Update: Mobilization of Stem Cells With Motixafortide (BL-8040) in Combination With G-CSF in Multiple Myeloma Patients [Phase 3]

View source ↗

Summary

This document provides an update on a Phase 3 trial evaluating Motixafortide (BL-8040) with G-CSF for stem cell mobilization in multiple myeloma. The study is s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• G-CSF (granulocyte colony-stimulating factor)
• Motixafortide (BL-8040) (Motixafortide)

Snippet

Sponsor: Guangzhou Gloria Biosciences Co., Ltd. | Conditions: Multiple Myeloma | Phase 3 | Status: RECRUITING